Rutgers Cancer Institute of New Jersey (CINJ) is the State of New Jersey's only National Cancer Institute (NCI)-designated Comprehensive Cancer Center. The mission of CINJ is to reduce the burden of cancer by advancing cancer research, prevention, screening and education for one of the nation?s most diverse and densely populated states and therefore considers the entire State of New Jersey (NJ) its catchment area. With 21 counties, New Jersey is one of the most racially, ethnically and socioeconomically diverse regions in the US. The State is home to a large immigrant and minority population. As a whole, New Jersey is a well- educated and high-income state. However, this statistic conceals disparities in education level, English language proficiency, immigrant status, income, population density, and access to cancer care. The three major cities in the State - Newark, Trenton, and Camden - have a large population of minority, low income, and immigrant residents. The age-adjusted incidence rate of cancer in NJ is significantly higher than the US average. NJ ranked 6th in the nation in 2010-2014 in cancer incidence rates. The top five cancers in NJ mirror the top cancers in the US. Incidence of prostate, lung, colorectal, bladder, and melanoma ranked highest among men. Incidence of breast, lung, colorectal, uterine, and thyroid cancers ranked highest among women. The top five cancer sites with the highest mortality rates include lung, prostate, colorectal, and pancreas, liver for men and ovarian cancer for women. Cancer mortality in NJ is higher than the US average for colorectal cancer (men and women) and breast and pancreas cancers (women). Although overall cancer incidence in NJ has declined, there have been significant increases in breast, kidney (women), leukemia, liver, oral (men), pancreatic, and uterine cancers. Work conducted by CINJ investigators has elucidated a number of disparities in cancer incidence and mortality with regard to race/ethnicity and geographic location. This information has been used to guide research and outreach activities. CINJ conducts research and delivers outreach services that focus on cancers that pose a significant burden to the NJ population. Research and outreach services address barriers to access to cancer care and prevention services and modify health behaviors that are associated with increased cancer risk.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Rbhs -Cancer Institute of New Jersey
New Brunswick
United States
Zip Code
Herman, Joseph M; Jabbour, Salma K; Lin, Steven H et al. (2018) Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation. Pancreas 47:208-212
Patrizii, Michele; Bartucci, Monica; Pine, Sharon R et al. (2018) Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy. Front Oncol 8:23
Zloza, Andrew (2018) Viruses, bacteria, and parasites - oh my! a resurgence of interest in microbial-based therapy for cancer. J Immunother Cancer 6:3
CeliĆ -Terrassa, Toni; Bastian, Caleb; Liu, Daniel et al. (2018) Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability. Nat Commun 9:5005
George, Blessy; Joy, Melanie S; Aleksunes, Lauren M (2018) Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy. Exp Biol Med (Maywood) 243:272-282
Paratala, Bhavna S; Chung, Jon H; Williams, Casey B et al. (2018) RET rearrangements are actionable alterations in breast cancer. Nat Commun 9:4821
Jian-Yu E; Graber, Judith M; Lu, Shou-En et al. (2018) Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis. Curr Med Chem 25:2595-2607
Moloughney, Joseph G; Vega-Cotto, Nicole M; Liu, Sharon et al. (2018) mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation. J Biol Chem 293:16464-16478
Zhu, Sining; Jin, Juan; Gokhale, Samantha et al. (2018) Genetic Alterations of TRAF Proteins in Human Cancers. Front Immunol 9:2111
Perekatt, Ansu O; Shah, Pooja P; Cheung, Shannon et al. (2018) SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium. Cancer Res 78:4878-4890

Showing the most recent 10 out of 775 publications